Newleos Therapeutics
Newleos Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
About Newleos Therapeutics
Newleos Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Newleos Therapeutics develops next-generation oral small-molecule therapies targeting neuropsychiatric disorders such as generalized anxiety disorder, social anxiety disorder, and substance use disorders by boosting the GABA system in the amygdala to deliver calming effects without sedation or dependence.
Explore Newleos Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.